Management of Chronic Respiratory Failure in Interstitial Lung Diseases: Overview and Clinical Insights
- PMID: 31341410
- PMCID: PMC6643124
- DOI: 10.7150/ijms.32752
Management of Chronic Respiratory Failure in Interstitial Lung Diseases: Overview and Clinical Insights
Abstract
Interstitial lung diseases (ILDs) may be complicated by chronic respiratory failure (CRF), especially in the advanced stages. Aim of this narrative review is to evaluate the current evidence in management of CRF in ILDs. Many physiological mechanisms underlie CRF in ILDs, including lung restriction, ventilation/perfusion mismatch, impaired diffusion capacity and pulmonary vascular damage. Intermittent exertional hypoxemia is often the initial sign of CRF, evolving, as ILD progresses, into continuous hypoxemia. In the majority of the cases, the development of CRF is secondary to the worsening of the underlying disease; however, associated comorbidities may also play a role. When managing CRF in ILDs, the need for pulmonary rehabilitation, the referral to lung transplant centers and palliative care should be assessed and, if necessary, promptly offered. Long-term oxygen therapy is commonly prescribed in case of resting or exertional hypoxemia with the purpose to decrease dyspnea and improve exercise tolerance. High-Flow Nasal Cannula oxygen therapy may be used as an alternative to conventional oxygen therapy for ILD patients with severe hypoxemia requiring both high flows and high oxygen concentrations. Non-Invasive Ventilation may be used in the chronic setting for palliation of end-stage ILD patients, although the evidence to support this application is very limited.
Keywords: Interstitial lung diseases; chronic respiratory failure; idiopathic pulmonary fibrosis; non-invasive ventilation; oxygen therapy.
Conflict of interest statement
Competing Interests: The authors have declared that no competing interest exists.
Figures
References
-
- Travis WD, Costabel U, Hansell DM, King TE, Lynch DA, Nicholson AG. et al. An official American Thoracic Society/European Respiratory Society statement: Update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med. 2013 Sep 15;188(6):733–48. - PMC - PubMed
-
- Bag R, Suleman N, Guntupalli KK. Respiratory failure in interstitial lung disease. Curr Opin Pulm Med. 2004 Sep;10(5):412–8. - PubMed
-
- Agustí AG, Roca J, Gea J, Wagner PD, Xaubet A, Rodriguez-Roisin R. Mechanisms of gas-exchange impairment in idiopathic pulmonary fibrosis. Am Rev Respir Dis. 1991 Feb;143(2):219–25. - PubMed
-
- Gläser S, Noga O, Koch B, Opitz CF, Schmidt B, Temmesfeld B. et al. Impact of pulmonary hypertension on gas exchange and exercise capacity in patients with pulmonary fibrosis. Respir Med. 2009 Feb;103(2):317–24. - PubMed
